MCOIF yields 30.56% · JNJ yields 2.13%● Live data
📍 MCOIF pulled ahead of the other in Year 1
Combined, MCOIF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MCOIF + JNJ for your $10,000?
MultiChoice Group Limited, through its subsidiaries, operates video-entertainment subscriber platforms in South Africa, rest of Africa, Europe, and internationally. It operates through South Africa, Rest of Africa, and Technology segments. The company offers digital satellite television, digital terrestrial television, online services, over-the-top, and related video-entertainment services. Its video-entertainment is a commercial service that provides packages of video and audio programming to consumers. The company also provides digital content management and protection systems to protect, manage, and monetize digital media on various platforms. In addition, it broadcasts advertisements on its video entertainment platforms and shows online on its websites; and sells set-top boxes. The company offers its services under the SuperSport, DStv, GOtv, M-Net, Showmax, and Irdeto names. It serves approximately 14 million people in 50 countries across various platforms. The company was founded in 1995 and is headquartered in Randburg, South Africa.
Full MCOIF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.